What is required to the manufacture of high-potency active pharmaceutical ingredients (HPAPIs)? Simply having a high-containment reactor is not enough to manufacture these complex molecules and drug-product intermediates based on them. This presentation explores best practices, based on Lonza's experience at its Center for Excellence in Visp, Switzerland, on the development, manufacture, and particle engineering required for success in HPAPI production. To learn more, please view our presentation.
Content Type: Webinar (on-demand)
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center